Research progress on the antihypertensive effect of sodium-glucose synergistic transporter 2 inhibitors / 中华全科医师杂志
Xiuqi QIAO; Jiaming CAO; Lina ZHANG; Qi PAN.
Chinese Journal of General Practitioners
; (6): 584-587, 2022.
Artículo
en Zh
| WPRIM | ID: wpr-957883
Diabetes mellitus is a chronic metabolic disease, in which the abnormality of glucose and lipid metabolism may cause multisystem damage. Sodium-glucose synergistic transporter 2 (SGLT2) inhibitors are a novel type of hypoglycemic drug that can lower blood sugar level by inhibiting the absorption of glucose through renal tubules. Studies have shown that SGLT2 inhibitors also have a lowering effect on blood pressure, but the mechanism is not fully elucidated. In this article the hypotensive effects of SGLT2 inhibitors and possible mechanisms are reviewed.
Biblioteca responsable:
WPRO
Texto completo
Documentos relacionados